Kepos Capital’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.86M | Hold |
30,000
| – | – | 14.46% | 1 |
|
|
2025
Q4 | $8.19M | Hold |
30,000
| – | – | 46.51% | 1 |
|
|
2025
Q3 | $8.11M | Hold |
30,000
| – | – | 43.07% | 1 |
|
|
2025
Q2 | $8.27M | Hold |
30,000
| – | – | 11.08% | 5 |
|
|
2025
Q1 | $7.96M | Hold |
30,000
| – | – | 6.59% | 9 |
|
|
2024
Q4 | $6.97M | Sell |
30,000
-168
| -0.6% | -$38.6K | 6.02% | 9 |
|
|
2024
Q3 | $6.66M | Buy |
30,168
+168
| +0.6% | +$34.8K | 2.92% | 6 |
|
|
2024
Q2 | $5.9M | Hold |
30,000
| – | – | 2.29% | 10 |
|
|
2024
Q1 | $6.46M | Hold |
30,000
| – | – | 1.67% | 17 |
|
|
2023
Q4 | $6.32M | Hold |
30,000
| – | – | 2.05% | 15 |
|
|
2023
Q3 | $6.01M | Hold |
30,000
| – | – | 1.06% | 19 |
|
|
2023
Q2 | $5.56M | Buy |
+30,000
| New | +$5.54M | 1.02% | 22 |
|
|
2022
Q4 | $5.04M | Hold |
30,000
| – | – | 0.73% | 36 |
|
|
2022
Q3 | $5.31M | Hold |
30,000
| – | – | 0.65% | 45 |
|
|
2022
Q2 | $6.14M | Hold |
30,000
| – | – | 0.56% | 64 |
|
|
2022
Q1 | $7.14M | Hold |
30,000
| – | – | 0.54% | 45 |
|
|
2021
Q4 | $6.85M | Hold |
30,000
| – | – | 0.57% | 40 |
|
|
2021
Q3 | $5.8M | Hold |
30,000
| – | – | 0.39% | 49 |
|
|
2021
Q2 | $6.38M | Hold |
30,000
| – | – | 0.47% | 35 |
|
|
2021
Q1 | $6.13M | Hold |
30,000
| – | – | 0.4% | 76 |
|
|
2020
Q4 | $5.46M | Hold |
30,000
| – | – | 0.48% | 80 |
|
|
2020
Q3 | $5.02M | Hold |
30,000
| – | – | 0.53% | 68 |
|
|
2020
Q2 | $4.88M | Hold |
30,000
| – | – | 0.63% | 61 |
|
|
2020
Q1 | $5.19M | Hold |
30,000
| – | – | 1.08% | 33 |
|
|
2019
Q4 | $6.02M | Hold |
30,000
| – | – | 0.57% | 40 |
|
|
2019
Q3 | $6.34M | Sell |
30,000
-14,500
| -33% | -$3.03M | 0.63% | 35 |
|
|
2019
Q2 | $8.64M | Buy |
44,500
+14,500
| +48% | +$2.67M | 0.88% | 18 |
|
|
2019
Q1 | $4.94M | Hold |
30,000
| – | – | 0.37% | 87 |
|
|
2018
Q4 | $5.64M | Hold |
30,000
| – | – | 0.44% | 67 |
|
|
2018
Q3 | $5.11M | Hold |
30,000
| – | – | 0.26% | 94 |
|
|
2018
Q2 | $4.92M | Hold |
30,000
| – | – | 0.25% | 98 |
|
|
2018
Q1 | $4.85M | Hold |
30,000
| – | – | 0.28% | 79 |
|
|
2017
Q4 | $4.38M | Hold |
30,000
| – | – | 0.39% | 57 |
|
|
2017
Q3 | $4.07M | Hold |
30,000
| – | – | 0.68% | 9 |
|
|
2017
Q2 | $3.76M | Hold |
30,000
| – | – | 0.9% | 9 |
|
|
2017
Q1 | $3.56M | Hold |
30,000
| – | – | 1.32% | 9 |
|
|
2016
Q4 | $3.46M | Hold |
30,000
| – | – | 1.81% | 9 |
|
|
2016
Q3 | $3.14M | Hold |
30,000
| – | – | 2.22% | 8 |
|
|
2016
Q2 | $2.92M | Buy |
+30,000
| New | +$2.84M | 3.59% | 8 |
|
Other funds holding CME
VCM
VPM
Kepos Capital's CME Position: Q1 2026 in Review
Kepos Capital held its CME Group (CME) position steady in Q1 2026 at 30,000 shares worth $8.86M. The position accounts for 14.46% of the portfolio, ranked #1.
Kepos Capital first reported a position in CME in Q2 2016 and has held it in 39 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- Kepos Capital held 30,000 shares of CME Group worth $8.86M as of Q1 2026.
- Kepos Capital left its CME Group share count unchanged in Q1 2026.
- CME Group made up 14.46% of Kepos Capital's portfolio in Q1 2026, its #1 holding.
- Kepos Capital first reported a position in CME Group in Q2 2016 and has held it in 39 quarters since.
- 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on Kepos Capital's 13F filing for Q1 2026, filed 12 May 2026.